Andruska Adam, Micek Scott T, Shindo Yuichiro, Hampton Nicholas, Colona Brian, McCormick Sandra, Kollef Marin H
Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO.
St. Louis College of Pharmacy, St. Louis, MO.
Chest. 2015 Jul;148(1):103-111. doi: 10.1378/chest.14-2129.
Hospital readmissions for pneumonia occur often and are difficult to predict. For fiscal year 2013, the Centers for Medicare & Medicaid Services readmission penalties have been applied to acute myocardial infarction, heart failure, and pneumonia. However, the overall impact of pneumonia pathogen characterization on hospital readmission is undefined.
This was a retrospective 6-year cohort study (August 2007 to September 2013).
We evaluated 9,624 patients with a discharge diagnosis of pneumonia. Among these patients, 4,432 (46.1%) were classified as having culture-negative pneumonia, 1,940 (20.2%) as having pneumonia caused by antibiotic-susceptible bacteria, 2,991 (31.1%) as having pneumonia caused by potentially antibiotic-resistant bacteria, and 261 (2.7%) as having viral pneumonia. The 90-day hospital readmission rate for survivors (n = 7,637, 79.4%) was greatest for patients with pneumonia attributed to potentially antibiotic-resistant bacteria (11.4%) followed by viral pneumonia (8.3%), pneumonia attributed to antibiotic-susceptible bacteria (6.6%), and culture-negative pneumonia (5.8%) (P < .001). Multiple logistic regression analysis identified pneumonia attributed to potentially antibiotic-resistant bacteria to be independently associated with 90-day readmission (OR, 1.75; 95% CI, 1.56-1.97; P < .001). Other independent predictors of 90-day readmission were Charlson comorbidity score > 4, cirrhosis, and chronic kidney disease. Culture-negative pneumonia was independently associated with lower risk for 90-day readmission.
Readmission after hospitalization for pneumonia is relatively common and is related to pneumonia pathogen characterization. Pneumonia attributed to potentially antibiotic-resistant bacteria is associated with an increased risk for 90-day readmission, whereas culture-negative pneumonia is associated with lower risk for 90-day readmission.
肺炎患者的医院再入院情况经常发生且难以预测。2013财年,医疗保险和医疗补助服务中心已将再入院处罚应用于急性心肌梗死、心力衰竭和肺炎。然而,肺炎病原体特征对医院再入院的总体影响尚不清楚。
这是一项回顾性6年队列研究(2007年8月至2013年9月)。
我们评估了9624例出院诊断为肺炎的患者。在这些患者中,4432例(46.1%)被归类为培养阴性肺炎,1940例(20.2%)为抗生素敏感菌引起的肺炎,2991例(31.1%)为潜在抗生素耐药菌引起的肺炎,261例(2.7%)为病毒性肺炎。幸存者(n = 7637,79.4%)的90天医院再入院率在潜在抗生素耐药菌引起的肺炎患者中最高(11.4%),其次是病毒性肺炎(8.3%)、抗生素敏感菌引起的肺炎(6.6%)和培养阴性肺炎(5.8%)(P <.001)。多因素logistic回归分析确定潜在抗生素耐药菌引起的肺炎与90天再入院独立相关(OR,1.75;95%CI,1.56 - 1.97;P <.001)。90天再入院的其他独立预测因素为Charlson合并症评分>4、肝硬化和慢性肾脏病。培养阴性肺炎与90天再入院风险较低独立相关。
肺炎住院后的再入院相对常见,且与肺炎病原体特征有关。潜在抗生素耐药菌引起的肺炎与90天再入院风险增加相关,而培养阴性肺炎与90天再入院风险较低相关。